Recurrent inactivating mutations of ARID2 in non-small cell lung carcinoma

International Journal of Cancer

Volumn 132, Issue 9, 2013, Pages 2217-2221

  Manceau, Gilles ^a   Letouzé, Eric ^b   Guichard, Cécile ^a   Didelot, Audrey ^a   Cazes, Aurelie ^c,d   Corté, Hélène ^a   Fabre, Elizabeth ^a,c   Pallier, Karine ^a   Imbeaud, Sandrine ^a   Le Pimpec Barthes, Françoise ^a,c,d   Zucman Rossi, Jessica ^a,d   Laurent Puig, Pierre ^a,c,d   Blons, Hélène ^a,c,d  

^a INSERM   (France)

^b Cartes d'Identité des Tumeurs Program Ligue Nationale Contre le Cancer   (France)

^c HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^d UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

ARID2; chromatin remodeling gene; JARID2; mutation; non small cell lung carcinoma

Indexed keywords

AT RICH INTERACTION DOMAIN 1A PROTEIN; CYCLIN DEPENDENT KINASE INHIBITOR 2A; DYSBINDIN; EPIDERMAL GROWTH FACTOR RECEPTOR; K RAS PROTEIN; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN KINASE LKB1; PROTEIN P53; PROTEIN SWI; RETINOBLASTOMA BINDING PROTEIN 2; SMAD4 PROTEIN; TRANSCRIPTION FACTOR SNF; TUMOR PROTEIN; UNCLASSIFIED DRUG;

ADULT; ARID2 GENE; ARTICLE; CANCER STAGING; CHROMATIN ASSEMBLY AND DISASSEMBLY; CONTROLLED STUDY; DNA EXTRACTION; FEMALE; FRAMESHIFT MUTATION; GENE DELETION; GENE FREQUENCY; GENE LOCUS; GENE MUTATION; GENE SEQUENCE; GENETIC SCREENING; HETEROZYGOSITY LOSS; HOMOZYGOSITY; HUMAN; HUMAN CELL; HUMAN TISSUE; LARGE CELL CARCINOMA; LOSS OF FUNCTION MUTATION; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MICROARRAY ANALYSIS; MISSENSE MUTATION; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SOMATIC MUTATION; TUMOR GENE;

ADENOCARCINOMA, BRONCHIOLO-ALVEOLAR; ADULT; AGED; BASE SEQUENCE; CARCINOMA, LARGE CELL; CARCINOMA, NON-SMALL-CELL LUNG; CHROMATIN ASSEMBLY AND DISASSEMBLY; DNA, NEOPLASM; FEMALE; GENE EXPRESSION PROFILING; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MUTATION; NEOPLASM STAGING; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; POLYCOMB REPRESSIVE COMPLEX 2; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSCRIPTION FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 84874111393     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.27900     Document Type: Article

References (26)

1. Olak J, Colson Y,. Gender differences in lung cancer: have we really come a long way, baby? J Thorac Cardiovasc Surg 2004; 128: 346-51.
2. Gazdar AF,. Personalized medicine and inhibition of EGFR signaling in lung cancer. N Engl J Med 2009; 361: 1018-20.
3. Ding L, Getz G, Wheeler DA, et al. Somatic mutations affect key pathways in lung adenocarcinoma. Nature 2008; 455: 1069-75.
4. Reisman D, Glaros S, Thompson EA,. The SWI/SNF complex and cancer. Oncogene 2009; 28: 1653-68.
5. Varela I, Tarpey P, Raine K, et al. Exome sequencing identifies frequent mutation of the SWI/SNF complex gene PBRM1 in renal carcinoma. Nature 2011; 469: 539-42.
6. Jones S, Wang TL, Shih Ie M, et al. Frequent mutations of chromatin remodeling gene ARID1A in ovarian clear cell carcinoma. Science 2010; 330: 228-31.
7. Wiegand KC, Shah SP, Al-Agha OM, et al. ARID1A mutations in endometriosis-associated ovarian carcinomas. N Engl J Med 2010; 363: 1532-43.
8. Gui Y, Guo G, Huang Y, et al. Frequent mutations of chromatin remodeling genes in transitional cell carcinoma of the bladder. Nat Genet 2011; 43: 875-8.
9. Li M, Zhao H, Zhang X, et al. Inactivating mutations of the chromatin remodeling gene ARID2 in hepatocellular carcinoma. Nat Genet 2011; 43: 828-9.
10. Hodis E, Watson IR, Kryukov GV, et al. A landscape of driver mutations in melanoma. Cell 2012; 150: 251-63.
11. Reisman DN, Sciarrotta J, Wang W, et al. Loss of BRG1/BRM in human lung cancer cell lines and primary lung cancers: correlation with poor prognosis. Cancer Res 2003; 63: 560-6.
12. Rodriguez-Nieto S, Canada A, Pros E, et al. Massive parallel DNA pyrosequencing analysis of the tumor suppressor BRG1/SMARCA4 in lung primary tumors. Hum Mutat 2010; 32: E1999-2017.
13. Blons H, Pallier K, Le Corre D, et al. Genome wide SNP comparative analysis between EGFR and KRAS mutated NSCLC and characterization of two models of oncogenic cooperation in non-small cell lung carcinoma. Biomed Chromatogr Med Genomics 2008; 1: 25.
14. Pallier K, Houllier AM, Le Corre D, et al. No somatic genetic change in the paxillin gene in nonsmall-cell lung cancer. Mol Carcinog 2009; 48: 581-5.
15. Peiffer DA, Le JM, Steemers FJ, et al. High-resolution genomic profiling of chromosomal aberrations using Infinium whole-genome genotyping. Genome Res 2006; 16: 1136-48.
16. Staaf J, Vallon-Christersson J, Lindgren D, et al. Normalization of Illumina Infinium whole-genome SNP data improves copy number estimates and allelic intensity ratios. Biomed Chromatogr Bioinformatics 2008; 9: 409.
17. Popova T, Manie E, Stoppa-Lyonnet D, et al. Genome Alteration Print (GAP): a tool to visualize and mine complex cancer genomic profiles obtained by SNP arrays. Genome Biol 2009; 10: R128.
18. Gentleman RC, Carey VJ, Bates DM, et al. Bioconductor: open software development for computational biology and bioinformatics. Genome Biol 2004; 5: R80.
19. Venkatraman ES, Olshen AB,. A faster circular binary segmentation algorithm for the analysis of array CGH data. Bioinformatics 2007; 23: 657-63.
20. Iafrate AJ, Feuk L, Rivera MN, et al. Detection of large-scale variation in the human genome. Nat Genet 2004; 36: 949-51.
21. Adzhubei IA, Schmidt S, Peshkin L, et al. A method and server for predicting damaging missense mutations. Nat Methods 2010; 7: 248-9.
22. Sauvageau M, Sauvageau G,. Polycomb group proteins: multi-faceted regulators of somatic stem cells and cancer. Cell Stem Cell 2010; 7: 299-313.
23. Beroukhim R, Mermel CH, Porter D, et al. The landscape of somatic copy-number alteration across human cancers. Nature 2010; 463: 899-905.
24. Lee W, Jiang Z, Liu J, et al. The mutation spectrum revealed by paired genome sequences from a lung cancer patient. Nature 2010; 465: 473-7.
25. Forbes SA, Bindal N, Bamford S, et al. COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer. Nucleic Acids Res 2011; 39: D945-50.
26. Guichard C, Amaddeo G, Imbeaud S, et al. Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma. Nature Genet 2012; 44: 694-8.